Market Currents
CVS Caremark (CVS +9.2%) shares obviously benefit from its predicted double-digit profit...
-
Tuesday, December 20, 2011, 4:02 PM ETCVS Caremark (CVS +9.2%) shares obviously benefit from its predicted double-digit profit increase in 2012 and 30% dividend hike, but it also touts the success of MinuteClinic, a wave of generics that is seen boosting profitability the next several years and customer wins if a contract spat between Walgreen (WAG) and Express Scripts (ESRX) continues into 2012.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
